After being alerted to a potential safety issue about the bivalent shot in November, the two agencies investigated whether ischemic strokes were more likely to happen within 21 days post-vaccination versus between 22 and 42 days, the CDC said in a statement.
The CDC listed five analyses to confirm the lack of a risk:
- A large study of updated bivalent vaccines using the CMS database revealed no increased risk of ischemic stroke.
- A preliminary study using the Veterans Affairs database did not indicate an increased risk of ischemic stroke following an updated vaccine.
- The Vaccine Adverse Event Reporting System managed by CDC and FDA has not seen an increase in reporting of ischemic strokes following the updated vaccine.
- Pfizer-BioNTech’s global safety database has not indicated a signal for ischemic stroke with the updated vaccine.
- Other countries have not observed an increased risk for ischemic stroke with updated vaccines.
The CDC said it will continue tracking data on vaccine safety.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
